WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards

     WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards

PR Newswire

SHANGHAI, Jan. 30, 2013

SHANGHAI, Jan. 30, 2013 /PRNewswire/ -- WuXi PharmaTech (NYSE:WX), a leading
pharmaceutical, biotechnology, and medical device research and development
outsourcing company with operations in China and the United States, announced
the winners of its 6th annual WuXi PharmaTech Life Science and Chemistry
Awards at a ceremony held on January 20, 2013.

Mr. Guowei Sang, Vice Chairman of the Standing Committee of the 11th National
People's Congress and a member of the Chinese Academy of Engineering, and Ms.
Zhizheng Wang, Vice Chairwoman of the 11th Chinese People's Political
Consultative Conference and a member of the Chinese Academy of Sciences,
presented the awards. Mr. Sang served as the Honorary Chairman of the award
selection committee, which was comprised of nine distinguished experts from
Chinese life science academia and industry.

Eighteen highly accomplished young scholars were honored through a rigorous
and transparent selection process that began in May 2012. Winners of the
Outstanding Achievements Awards included:

  oProf. Rui Wang, School of Basic Medical Science, Lanzhou University
  oProf. Hongyan Wang, School of Life Sciences, Fudan University
  oProf. Qiao Wu, School of Life Sciences,Xiamen University

Winners of the Scholar Awards included:

  oProf. Liu Cao, Translational Medicine Research Institute,China Medical
    University
  oDr. Ke Ding, Guangzhou Institutes of Biomedicine and Health, Chinese
    Academy of Sciences
  oProf. Zhike He, College of Chemistry and Molecular Sciences, Wuhan
    University
  oProf. Tuo Jin, School of Pharmacy, Shanghai Jiao Tong University
  oProf. Ke Lan, Institute Pasteur of Shanghai, Chinese Academy of Sciences
  oProf. Lei Liu, Department of Chemistry, Tsinghua University
  oDr. Zhijie Liu, Institute of Biophysics, Chinese Academy of Sciences
  oProf. Zhangjie Shi, College of Chemistry and Molecular Engineering, Peking
    University
  oDr. Xiaocheng Wang, National Institute of Biological Sciences
  oDr. Xin Xie, Shanghai Institute of Materia Medica, Chinese Academy of
    Sciences
  oProf. Ning Yan, School of Medicine, Tsinghua University
  oProf. Shengyong Yang, State Key Laboratory of Biological Treatment,
    Sichuan University
  oDr. Tao Ye, Shenzhen Graduate School, Peking University,and Hong Kong
    Polytechnic University
  oDr. Ao Zhang, Shanghai Institute of Materia Medica, Chinese Academy of
    Sciences
  oDr. Bing Zhu, National Institute of Biological Sciences

"I would like to express my gratitude to WuXi PharmaTech and the distinguished
selection committee for their recognition of our research," said Prof. Hongyan
Wang, one of the winners of the Outstanding Achievements Awards. "We hope that
results from our research laboratories may one day benefit patients and their
families."

"Congratulations to all of the award winners for their exceptional scientific
accomplishments," commented Dr. Ge Li, Chairman and Chief Executive Officer of
WuXi PharmaTech. "WuXi is delighted to present this award to recognize some of
the brightest minds in China whose research can help our global industry to
better understand diseases and find more effective cures. Advancing innovation
to therapies is an enormous challenge that requires strong partnership between
academia and industry. Our vision at WuXi is to build a technology and
capability platform to enable anyone and any company to discover and develop
drugs more efficiently and cost effectively to benefit patients in need around
the world."

The WuXi PharmaTech Life Science and Chemistry Awards were originated in 2007
as the first nationwide scientific award in China established by a life
science enterprise. The awards aim to foster early innovation and encourage
pursuit of excellence in life science research. During the six years since
its inception, 95 scholars from more than 30 premier Chinese universities and
research institutes have received awards, of whom three were later elected to
the Chinese Academy of Sciences or the Chinese Academy of Engineering.

About WuXi PharmaTech

As a research-driven and customer-focused company, WuXi PharmaTech provides a
broad and integrated portfolio of laboratory and manufacturing services
throughout the drug and medical device R&D process. WuXi PharmaTech's services
are designed to assist its global partners in shortening the cycle and
lowering the cost of drug and medical device R&D. WuXi AppTec is the name for
the operating subsidiaries of WuXi PharmaTech. For more information, please
visit: http://www.wuxiapptec.com.

WuXi PharmaTech's Contacts:

Ronald Aldridge, Director of Investor Relations
+1 (201) 585-2048
ron_aldridge@wuxiapptec.com

Aaron Shi, Assistant Director, Corporate Communications
+86-21-5046-4362
aaron_shi@wuxiapptec.com

SOURCE WuXi PharmaTech (Cayman) Inc.

Website: http://www.wuxiapptec.com